Member Info for GlenFidrich

What I refer to as the "incontinent investor" seems to be rearing their ugly head. We're all doomed - apparently. Our hard-earned is about to evaporate. We should sell while we can. Blah, blah, blah. I beg to differ. No news on AIM is a like a red rag to a bull (and, perhaps, a green light to a bear). It is what it is. No amount of wishful thinking will speed up the processes UFO is now duty-bound to follow. We simply must wait - patiently. But the "I want instant riches, and I want it now" brigade are amongst us, spreading their hate and FUD. I would simply remind people that only a couple of months ago the UFO sp stood at around 0.40p. We're, as I type, 25% higher. So what do people want? I'm reminded of Lear's Aristotle: "The incontinent man fails to know what he thinks he knows - in fact, fails to believe what he thinks he believes". Trust your research - if, indeed, you have even bothered to do your research - and believe. One would think Rod M epitomizes that belief, surely? GLA.

OK, Sain. How about we have a wager? SP higher at the end of 2023 than now, or lower? I'll wager higher. You're obviously bearish, so lower? The amount of the wager? I'm easy, but how about lunch at a Michelin-starred restaurant of the winner's choice? Deal?

Sain, are you really that naive? I suggest you need to grow up. As I mentioned before, 87% of Trustpilot reviews for PURP are 5-star, yet you only choose to quote the bad ones, and Mark Walker (the Director of his own estate agency!) questions (or, rather, mocks) the veracity of any positive review. You don't think he possibly has an axe to grind, lol? He also suggests that PURP is a "strong sell". If that's the case, one would expect that he no longer holds any shares in the company (if, indeed, he was ever invested in the first place), and so why on earth is he still posting comments on this bb, unless of course they are intended to undermine confidence in PURP? Indeed, the same could be said of you. Your posting history shows your (some might say, unhealthy) obsession with everything PURP. To be honest, Sain, it's frankly boring, pathetic, and tantamount to stalking (so not a little creepy, if we're honest). Maybe, in 2023, see a shrink? Just a thought...

Hi batonrouge, as far as I know, 1801 was never used as part of the AGILE programme, which was supposedly meant to "fast-track" potential Covid treatments. This is what irks me the most, and probably a few others. We were issued an RNS on 1/7/21 to say that, pre-clinical, 1801 had been proven to be at least as efficacious as Baricitinib (the apparent Covid "wonder drug"), yet without its potential side effects. Happy days, I hear you say. Indeed, and it's probably what attracted some additional investment (in particular, from the HNWIs) in the weeks subsequent to that RNS. Since then, there has been nothing - no follow up, no update re: AGILE, no action. This, for me, is the biggest question mark over the BoD. Why on earth didn't they run with the Covid angle? The potential was there, and the momentum was there, yet they took their eye off the prize. This was a lost opportunity, and a major misstep in my opinion. I remain confident, but I have to question the Board's commercial nous. Anyway, I'm hopeful that 2023 will provide us with a more certain direction of travel - CTA approval, return of 737, will both surely prove to be positive catalysts. Happy New Year, one and all.

Kram (aka Mark Walker) - you wouldn't be the same Mark Geoffrey Walker who is listed as a director of Crendon House Lettings, obviously a competitor of Purplebricks, would you?
https://youcontrol.com.ua/en/catalog/gb-card/12952857/
A bit below the belt, wouldn't you say? If you're going to discredit a competitor, you really should try a bit harder to cover your tracks, lol! Nice try, though!

...of why Alien hired Troy Wittaker ("who will assume Bill's duties") in the first place: https://www.proactiveinvestors.co.uk/companies/news/996823/alien-metals-hires-ex-fortescue-executive-troy-whittaker-to-run-australian-subsidiary-996823.html
Also, I thought the following was a useful and recent overview of what Alien is all about (apologies if this has already been posted) for any new investors:
https://www.mining-journal.com/resourcestocks/resourcestocks/1444614/han****-iron-ore-project-update
Lots to look forward to in 2023 - inshallah.

OK, all fair comment. I guess I'm more hopeful that things will turnaround. This from Helena Marston on 8/12/22: "Outlook and guidance:
· Reiterating FY23 revenue guidance to be between £67.5 - £72.5m
· FY23 EBITDA expected to be in line with market consensus
· Positive cash generation expected in early FY24". Not long to wait, in other words.
Also this:
"· Stabilised instruction numbers
· Annualised cost savings increased from £13m to £17m
· Purplebricks Financial Services launched five months ahead of plan
· New marketing campaign from October driving 6ppts increase in consideration
· Financial benefits of the plan will start to come through in H2 and drive positive cash generation early in FY24".
sain, we're obviously reading the same info, but you're seeing doom and gloom, whereas I'm seeing green shoots. Let's agree to differ, but let's not gloss over the positives, whilst at the same time recognizing the challenges ahead.

sain@vision, you're very good at quoting the negative reviews on Trustpilot, and at talking PURP down at every given opportunity, ad nauseam. But the truth of the matter is that 87% of the reviews on Trustpilot give PURP a 5-star rating, something which you somehow neglect to mention. As recently as 21/12/22, we read this: "From start to finish I always had the support and weekly updates from my agent - Diane Armstrong. She was always on hand to provide me with advice and the next steps going forward. I would strongly recommend her and Purple Bricks. Thank you". There are many reviews like this, praising individual agents who are trying their best. I'm sure there have been many failings at PURP hitherto, as reflected in the current share price. But maybe, just maybe, the tide is turning and the good people at PURP (of which there are many, if you care to read ALL the reviews) are getting their act together. You seem to have some kind of bitter and twisted vendetta against the company - we get it, you bought high and sold low (always a flawed investment strategy if we're brutally honest) - but please give credit where credit is due and stop with the highly selective reviews which are clearly intended to mislead. Here's to happy and prosperous 2023!

5x5 looks like a sell to me, but I could be wrong...

Here we go again. The share price last Friday before the AGM touched 55p/57.5p. We now stand at 80p/82.5p. That's a near 40% increase in a matter of days, and you're bemoaning "further falls". Jeez, there's no pleasing some people...

A 30-bag from here? Stranger things have happened... Plenty of commentators in the PM space predicting triple digit silver (Peter Krauth is worth checking out, as he lays out the investment argument, along side the industrial use narrative). From $100 an ounce, $300 is not such a stretch, nor, too, $600. It will require "the herd" to reach such heights (as Krauth points out), but is anyone watching the current debt crisis and the devaluation of currencies? Central banks the world over have boxed themselves into a corner. It's either crash the economy (and all the political turmoil that that entails), or inflate to infinity. PMs are your only salvation, imo.

Lyndon, I think that's a little off 'Topic'!

Gunner is correct regarding "bids". The word used was "approaches", of which it seems there have been a fair few - "it's a case of form an orderly queue" (as Stephen Parker said). I think we can assume that there is a lot of interest in SRA737, once it has been returned, and once all the trial data gathered thus far have been poured over. As for timelines, I think Dr Parker said "a low number of weeks" to receive the data package, and "a low number of weeks" for the information to be assimilated. This might take us reasonably to the end of February, so share price volatility may continue for a while yet. For those capable of waiting, the current share price looks like an absolute steal to me, especially given the confidence we saw exuding from the Board last Friday. They were as exasperated as we are, but they didn't look at all worried. Just my take...

Warty, have you ever tried drinking diesel?

Many thx, PCS. Feedback most welcome, and thank you for attending (given the weather and current state of UK public transport).

Thx for the replies. They're all sounding quite bullish despite the delays, I have to say. Feeling a little more confident here.

Re: 737? Did I hear that right?

Problems with my connection, too. Keeps on cutting out...

Anyone care to hazard a guess as to where the pathway to CT approval might be "quicker and clearer"? I somehow doubt it would be any easier in the US, so perhaps looking east? Japan, China? I'm probably wrong, but I seem to remember we have patent protection in those countries... Sadly, though, this is looking more and more like a protracted delay, and therefore more SP slippage. Our one savior may yet be SRA737, but that also looks like a fairly distant hope (time wise). AGM will be interesting.

Gunner, I doubt TM and JR would ever indulge in such corrupt practices. But, the thought had crossed my mind with regard to MHRA. How many publicly listed companies have had their initial clinical trial applications denied? Someone mentioned a figure of 50% get pushed back, but how many of those companies would then see their share price tank as a result (because they are publicly traded)? Now that would be an interesting statistic, if anyone might know...